Linker Design Trends & Implications for Enhanced Radiopharmaceutical Agents’ PD/PK

• Covering the latest trends and innovations in linker design
• Appreciating implications for radiopharmaceutical properties
• Exploring strategies including plasma protein binding, covalent binding, charge and hydrophobicity, and enzymatic cleavage

Speakers:

Sujiet Puthenveetil

Director - Antibody Drug Conjugates & Radioconjugates

AstraZeneca